{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:56:15Z","timestamp":1784141775637,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although the clinical practice guideline for outpatient management of febrile neutropenia (FN) in adults treated for malignancy was updated by the ASCO\/IDSA in 2018, most patients with FN in our hospital have been hospitalized. We performed this study to analyze the usefulness of the guideline. The medical records of patients hospitalized for FN in Kyungpook National University Chilgok Hospital from May 2016 to April 2018 were retrospectively reviewed. The feasibility of candidates for outpatient management according to the guideline was evaluated based on the outcomes. A total of 114 patients were enrolled and categorized into two groups, low-risk (38.6%) and high-risk (61.4%). The proportion of feasible candidates for outpatient management was 70.2% and was higher in the low-risk than in the high-risk group (90.0% vs. 57.1%; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The low-risk group had no mortality, no resistance to oral amoxicillin\/clavulanate or ciprofloxacin, a higher rate of successful empirical antibiotics, and lower rates of glycopeptide or carbapenem administration. A significant number of hospitalized cancer patients treated for FN after chemotherapy were found to be feasible candidates for outpatient management. The guideline can be a useful tool to reduce labor of healthcare workers and hospitalization costs.<\/jats:p>","DOI":"10.1038\/s41598-021-88207-6","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T10:03:59Z","timestamp":1631700239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Usefulness analysis of the 2018 ASCO\/IDSA guideline for outpatient management of fever and neutropenia in adults treated for malignancy"],"prefix":"10.1038","volume":"11","author":[{"given":"Soyoon","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4666-0672","authenticated-orcid":false,"given":"Ki Tae","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonjung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohyun","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Ha","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Soo","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Youn","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Ho","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"key":"88207_CR1","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","volume":"36","author":"RA Taplitz","year":"2018","unstructured":"Taplitz, R. A. et al. Outpatient management of fever and neutropenia in adults treated for malignancy: American society of clinical oncology and infectious diseases society of America clinical practice guideline update. J. Clin. Oncol. 36, 1443\u20131453. https:\/\/doi.org\/10.1200\/JCO.2017.77.6211 (2018).","journal-title":"J. Clin. Oncol."},{"key":"88207_CR2","unstructured":"Hong, S. J., Youk, T. M., Lee, S. H., You, H. M. & Lee, E. K. Research on the distrubution, treatment, and cost of febrile neutropenia in major cancer patients. (National Health Insurance Service Ilsan Hospital Institute of Health Insurance & Clinical Research, 2015)."},{"key":"88207_CR3","doi-asserted-by":"publisher","first-page":"e552","DOI":"10.1200\/JOP.2016.019588","volume":"13","author":"E Tai","year":"2017","unstructured":"Tai, E., Guy, G. P., Dunbar, A. & Richardson, L. C. Cost of cancer-related neutropenia or fever hospitalizations, United States, 2012. J. Oncol. Pract. 13, e552\u2013e561 (2017).","journal-title":"J. Oncol. Pract."},{"key":"88207_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1445-5994.2010.02343.x","volume":"41","author":"S Lingaratnam","year":"2011","unstructured":"Lingaratnam, S. et al. The disease and economic burden of neutropenic fever in adult patients in Australian cancer treatment centres 2008: analysis of the Victorian Admitted Episodes Dataset. Intern. Med. J. 41, 121\u2013129 (2011).","journal-title":"Intern. Med. J."},{"key":"88207_CR5","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1634\/theoncologist.2011-0456","volume":"17","author":"PM Livingston","year":"2012","unstructured":"Livingston, P. M., Craike, M. & Slavin, M. Clinical and economic burden of emergency department presentations for neutropenia following outpatient chemotherapy for cancer in Victoria, Australia. Oncologist. 17, 998 (2012).","journal-title":"Oncologist."},{"key":"88207_CR6","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1200\/JCO.2011.35.1247","volume":"29","author":"AM Hendricks","year":"2011","unstructured":"Hendricks, A. M., Loggers, E. T. & Talcott, J. A. Costs of home versus inpatient treatment for fever and neutropenia: Analysis of a multicenter randomized trial. J. Clin. Oncol. 29, 3984 (2011).","journal-title":"J. Clin. Oncol."},{"key":"88207_CR7","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0196-0644(00)70105-3","volume":"35","author":"RW Derlet","year":"2000","unstructured":"Derlet, R. W. & Richards, J. R. Overcrowding in the nation\u2019s emergency departments: Complex causes and disturbing effects. Ann. Emerg. Med. 35, 63\u201368 (2000).","journal-title":"Ann. Emerg. Med."},{"key":"88207_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/1735-1995.199095","volume":"22","author":"MH Yarmohammadian","year":"2017","unstructured":"Yarmohammadian, M. H., Rezaei, F., Haghshenas, A. & Tavakoli, N. Overcrowding in emergency departments: A review of strategies to decrease future challenges. J. Res. Med. Sci. 22, 1\u201323 (2017).","journal-title":"J. Res. Med. Sci."},{"key":"88207_CR9","unstructured":"Departament of Health. The NHS Plan: A Plan For Investment, A Plan For Reform. 1\u2013147. (Stationery Office, 2000)."},{"key":"88207_CR10","first-page":"1201","volume":"29","author":"BW Kim","year":"2018","unstructured":"Kim, B. W. & Yoon, Y. I. Developing the data analysis-based emergency room congestion predictive model for the resolution of overcrowded emergency room. J. Korean. Data. Inf. Sci. Soc. 29, 1201\u20131214 (2018).","journal-title":"J. Korean. Data. Inf. Sci. Soc."},{"key":"88207_CR11","doi-asserted-by":"publisher","first-page":"e0216835","DOI":"10.1371\/journal.pone.0216835","volume":"14","author":"CW Baugh","year":"2019","unstructured":"Baugh, C. W., Faridi, M. K., Mueller, E. L., Camargo, C. A. Jr. & Pallin, D. J. Near-universal hospitalization of US emergency department patients with cancer and febrile neutropenia. PLoS ONE 14, e0216835 (2019).","journal-title":"PLoS ONE"},{"key":"88207_CR12","unstructured":"OECD Indicators. Health at a Glance 2019. (2019)."},{"key":"88207_CR13","doi-asserted-by":"publisher","first-page":"812","DOI":"10.5124\/jkma.2012.55.9.812","volume":"55","author":"JH Hwang","year":"2012","unstructured":"Hwang, J. H. Lack of public health personnel, is it just a matter of doctor supply and demand?. J. Korean. Med. Assoc. 55, 812\u2013814 (2012).","journal-title":"J. Korean. Med. Assoc."},{"key":"88207_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5807\/kjohn.2014.23.1.11","volume":"23","author":"HN Cho","year":"2002","unstructured":"Cho, H. N. & Kim, S. J. Relationship of job stress, hardness, and burnout among emergency room nurses. Korean. J. Occup. Health Nurs. 23, 11\u201319. https:\/\/doi.org\/10.5807\/kjohn.2014.23.1.11 (2002).","journal-title":"Korean. J. Occup. Health Nurs."},{"key":"88207_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/00075197-200209000-00010","volume":"5","author":"SA Kavouras","year":"2002","unstructured":"Kavouras, S. A. Assessing hydration status. Curr. Opin. Clin. Nutr. Metab. Care. 5, 519\u2013524. https:\/\/doi.org\/10.1097\/00075197-200209000-00010 (2002).","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care."},{"key":"88207_CR16","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1093\/cid\/cir073","volume":"52","author":"AG Freifeld","year":"2011","unstructured":"Freifeld, A. G. et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America. Clin. Infect. Dis. 52, e56-93. https:\/\/doi.org\/10.1093\/cid\/cir073 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"88207_CR17","unstructured":"Team, R. C. R: A Language and Environment for Statistical Computing. (2013)."},{"key":"88207_CR18","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00520-007-0383-z","volume":"16","author":"C Sebban","year":"2008","unstructured":"Sebban, C. et al. Oral moxifloxacin or intravenous ceftriaxone for the treatment of low-risk neutropenic fever in cancer patients suitable for early hospital discharge. Support. Care. Cancer. 16, 1017\u20131023 (2008).","journal-title":"Support. Care. Cancer."},{"issue":"Suppl 5","key":"88207_CR19","doi-asserted-by":"publisher","first-page":"v252","DOI":"10.1093\/annonc\/mdq196","volume":"21","author":"J De Naurois","year":"2010","unstructured":"De Naurois, J. et al. Management of febrile neutropenia: ESMO clinical practice guidelines. Ann. Oncol. 21(Suppl 5), v252-256. https:\/\/doi.org\/10.1093\/annonc\/mdq196 (2010).","journal-title":"Ann. Oncol."},{"key":"88207_CR20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/CCO.0b013e3281214436","volume":"19","author":"H Innes","year":"2007","unstructured":"Innes, H. & Marshall, E. Outpatient therapy for febrile neutropenia. Curr. Opin. Oncol. 19, 294\u2013298 (2007).","journal-title":"Curr. Opin. Oncol."},{"key":"88207_CR21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.12746\/swrccc.v3i9.186","volume":"3","author":"N Hosiriluck","year":"2015","unstructured":"Hosiriluck, N. & Radhi, S. Febrile neutropenia in intensive care unit. Southwest. Respir. Crit. Care. Chronicle. 3, 19\u201324 (2015).","journal-title":"Southwest. Respir. Crit. Care. Chronicle."},{"key":"88207_CR22","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1001\/archinte.1988.00380120031007","volume":"148","author":"JA Talcott","year":"1988","unstructured":"Talcott, J. A., Finberg, R., Mayer, R. J. & Goldman, L. The medical course of cancer patients with fever and neutropenia: Clinical identification of a low-risk subgroup at presentation. Arch. Intern. Med. 148, 2561\u20132568 (1988).","journal-title":"Arch. Intern. Med."},{"key":"88207_CR23","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","volume":"18","author":"J Klastersky","year":"2000","unstructured":"Klastersky, J. et al. The multinational association for supportive care in cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J. Clin. Oncol. 18, 3038\u20133051 (2000).","journal-title":"J. Clin. Oncol."},{"key":"88207_CR24","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/bjc.2011.284","volume":"105","author":"A Carmona-Bayonas","year":"2011","unstructured":"Carmona-Bayonas, A. et al. Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients. Br. J. Cancer. 105, 612\u2013617 (2011).","journal-title":"Br. J. Cancer."},{"key":"88207_CR25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.annemergmed.2016.11.007","volume":"69","author":"CJ Coyne","year":"2017","unstructured":"Coyne, C. J. et al. Application of the MASCC and CISNE risk-stratification scores to identify low-risk febrile neutropenic patients in the emergency department. Ann. Emerg. Med. 69, 755\u2013764. https:\/\/doi.org\/10.1016\/j.annemergmed.2016.11.007 (2017).","journal-title":"Ann. Emerg. Med."},{"key":"88207_CR26","doi-asserted-by":"publisher","first-page":"e0210019","DOI":"10.1371\/journal.pone.0210019","volume":"13","author":"H Moon","year":"2018","unstructured":"Moon, H., Choi, Y. J. & Sim, S. H. Validation of the clinical index of stable febrile neutropenia (CISNE) model in febrile neutropenia patients visiting the emergency department: Can it guide emergency physicians to a reasonable decision on outpatient vs inpatient treatment?. PLoS ONE 13, e0210019. https:\/\/doi.org\/10.1371\/journal.pone.0210019 (2018).","journal-title":"PLoS ONE"},{"key":"88207_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7812\/TPP\/14-188","volume":"19","author":"RA Bitar","year":"2015","unstructured":"Bitar, R. A. Utility of the multinational association for supportive care in cancer (MASCC) risk index score as a criterion for nonadmission in febrile neutropenic patients with solid tumors. Perm. J. 19, 37\u201347. https:\/\/doi.org\/10.7812\/TPP\/14-188 (2015).","journal-title":"Perm. J."},{"key":"88207_CR28","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1200\/JCO.1992.10.2.316","volume":"10","author":"JA Talcott","year":"1992","unstructured":"Talcott, J. A., Siegel, R. D., Finberg, R. & Goldman, L. Risk assessment in cancer patients with fever and neutropenia: A prospective, two-center validation of a prediction rule. J. Clin. Oncol. 10, 316\u2013322 (1992).","journal-title":"J. Clin. Oncol."},{"key":"88207_CR29","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1200\/JCO.2014.57.2347","volume":"33","author":"A Carmona-Bayonas","year":"2015","unstructured":"Carmona-Bayonas, A. et al. Prediction of serious complications in patients with seemingly stable febrile neutropenia: Validation of the clinical index of stable febrile neutropenia in a prospective cohort of patients from the FINITE study. J. Clin. Oncol. 33, 465\u2013471. https:\/\/doi.org\/10.1200\/JCO.2014.57.2347 (2015).","journal-title":"J. Clin. Oncol."},{"key":"88207_CR30","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/bjc.2011.101","volume":"104","author":"O Teuffel","year":"2011","unstructured":"Teuffel, O., Amir, E., Alibhai, S., Beyene, J. & Sung, L. Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients. Br. J. Cancer. 104, 1377\u20131383 (2011).","journal-title":"Br. J. Cancer."},{"key":"88207_CR31","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1200\/JCO.2007.13.8222","volume":"26","author":"LS Elting","year":"2008","unstructured":"Elting, L. S. et al. Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia. J. Clin. Oncol. 26, 606\u2013611 (2008).","journal-title":"J. Clin. Oncol."},{"key":"88207_CR32","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.7314\/APJCP.2013.14.2.1115","volume":"14","author":"J Chindaprasirt","year":"2013","unstructured":"Chindaprasirt, J. et al. Mortality, length of stay, and cost associated with hospitalized adult cancer patients with febrile neutropenia. Asian Pac. J. Cancer Prev. 14, 1115\u20131119 (2013).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"88207_CR33","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/cncr.24773","volume":"116","author":"N Lathia","year":"2010","unstructured":"Lathia, N. et al. Evaluation of direct medical costs of hospitalization for febrile neutropenia. Cancer 116, 742\u2013748. https:\/\/doi.org\/10.1002\/cncr.24773 (2010).","journal-title":"Cancer"},{"key":"88207_CR34","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1200\/JCO.2016.34.15_suppl.6614","volume":"34","author":"E Tai","year":"2016","unstructured":"Tai, E., Guy, G. P. & Richardson, L. C. Cost of neutropenia hospitalizations among cancer patients in the United States. Am. Soc. Clin. Oncol. 34, 6614\u20136614 (2016).","journal-title":"Am. Soc. Clin. Oncol."},{"key":"88207_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/14651858.CD009031.pub2","volume":"5","author":"RR Rodolfo","year":"2019","unstructured":"Rodolfo, R. R., Miguel, V. K., Guadalupe, M. N., Osvaldo, D. C. M. & Silvia, R. C. Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event. Cochrane Database Syst. Rev. 5, 2. https:\/\/doi.org\/10.1002\/14651858.CD009031.pub2 (2019).","journal-title":"Cochrane Database Syst. Rev."},{"key":"88207_CR36","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00520-010-0928-4","volume":"19","author":"S Ahn","year":"2011","unstructured":"Ahn, S. et al. Predictive factors of poor prognosis in cancer patients with chemotherapy-induced febrile neutropenia. Support. Care Cancer. 19, 1151\u20131158 (2011).","journal-title":"Support. Care Cancer."},{"key":"88207_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/2183179","volume":"2018","author":"SJ Lee","year":"2018","unstructured":"Lee, S. J., Kim, J. H., Han, S. B., Paik, J. H. & Durey, A. Prognostic factors predicting poor outcome in cancer patients with febrile neutropenia in the emergency department: usefulness of qSOFA. J. Oncol. 2018, 1\u20137 (2018).","journal-title":"J. Oncol."},{"key":"88207_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0163-4453(03)00044-6","volume":"47","author":"S Gen\u00e7er","year":"2003","unstructured":"Gen\u00e7er, S., Salep\u00e7i, T. & \u00d6zer, S. Evaluation of infectious etiology and prognostic risk factors of febrile episodes in neutropenic cancer patients. J. Infect. 47, 65\u201372 (2003).","journal-title":"J. Infect."},{"key":"88207_CR39","doi-asserted-by":"publisher","first-page":"575S","DOI":"10.1080\/07315724.2007.10719661","volume":"26","author":"LE Armstrong","year":"2007","unstructured":"Armstrong, L. E. Assessing hydration status: the elusive gold standard. J. Am. Coll. Nutr. 26, 575S-584S (2007).","journal-title":"J. Am. Coll. Nutr."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88207-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88207-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88207-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T07:30:29Z","timestamp":1670052629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88207-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["88207"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-88207-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"assertion":[{"value":"7 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9048"}}